Compare GDOT & FLGT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | GDOT | FLGT |
|---|---|---|
| Founded | 1999 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | Medical Specialities |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 645.7M | 525.3M |
| IPO Year | 2010 | 2016 |
| Metric | GDOT | FLGT |
|---|---|---|
| Price | $12.52 | $16.02 |
| Analyst Decision | Sell | Buy |
| Analyst Count | 2 | 3 |
| Target Price | $11.00 | ★ $28.33 |
| AVG Volume (30 Days) | ★ 540.6K | 502.8K |
| Earning Date | 05-07-2026 | 05-01-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.33 | N/A |
| Revenue | ★ $2,080,491,000.00 | $18,730,000.00 |
| Revenue This Year | $11.07 | $10.09 |
| Revenue Next Year | $5.69 | $12.18 |
| P/E Ratio | $37.61 | ★ N/A |
| Revenue Growth | ★ 20.69 | N/A |
| 52 Week Low | $7.60 | $13.46 |
| 52 Week High | $15.41 | $31.04 |
| Indicator | GDOT | FLGT |
|---|---|---|
| Relative Strength Index (RSI) | 70.68 | 47.43 |
| Support Level | $11.92 | $15.39 |
| Resistance Level | $12.51 | $16.88 |
| Average True Range (ATR) | 0.22 | 0.66 |
| MACD | 0.15 | 0.23 |
| Stochastic Oscillator | 92.46 | 69.33 |
Green Dot Corp is a financial technology company that provides financial services for consumers in the United States without good banking options. It has three segments Consumer Services, Business to Business Services(B2B), and Money Movement Services. The company generates maximum revenue from B2B segment. Its B2B Services segment consists of revenues and expenses derived from (i) its partnerships with prominent consumer and technology companies that make banking products and services available to their consumers, partners and workforce through integration with its banking platform (the "Banking-as-a-Service", or "BaaS channel"), and (ii) a comprehensive payroll platform that it offers to corporate enterprises (the "Employer channel") to facilitate payments for todays workforce.
Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. The company is engaged in the laboratory services business and the therapeutic development business. The laboratory services business, which generates key revenue, includes technical laboratory services and professional interpretation of laboratory results by licensed physicians. Its therapeutic development business is focused on developing drug candidates for treating a broad range of cancers. The geographical segments are the United States, which generates the vast majority of the revenue, and Foreign.